mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.091 |
0.1 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.1 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.1 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |